Its backers include Astellas Venture Management, Avlar Bioventures, IP Group, Sofinnova Partners, Takeda Ventures, and the UK Innovation & Science Seed Fund. In 2020, Crescendo Biologics also ranked on the Pharma Times: Alantra Pharma Fast 50 high-growth list and 1000 Companies to Inspire Britain...
Lambda Therapeutic Research: Leading full-service CRO for biotech & pharma, with a proven track record & award-winning regulatory excellence.
MA - Boston iNGENu CRO | The FDA-centric CRO HQ’ed in Australia, with global offices (Asia, UK, EU, USA). Delivering high-quality clinical research at a fraction of the cost. Innate Biotherapeutics MA - Boston Immunotherapies InnoVoyce MA - Boston ENT Lasers Inozyme Pharma MA - Boston ...
UK's Biolndustry Association (BIA) is keen on exploring collaboration opportunities for its members with Indian biotech and pharma companies. The BIA recently brought a trade delegation consisting of small and medium-sized UK biopharma companies to India. The delegation's visit was facilitated by ...
Search the UK Biotech Database and identify potential partners in the UK Biotech, Pharma and Medtech industry
Although the EMA or FDA have approved only two products from UK biotechs since 2018, CEOs explained that’s because UK companies often out-license their assets to large pharma. Globally, there is a trend in biotech toward launches being the companies’ first; 27 percent between 20...
obn One Nucleus The UK Biotech Database is part of the global sourcing platform Biotechgate and property of Venture Valuation, Zurich, Switzerland. Biotechgate Venture Valuation Contact us » Looking for companies outside of United Kingdom?
The Covid premium A spotlight was shone on British Big Pharma in the pandemic era when Cambridge-based megacap AstraZeneca led the charge in developing a COVID-19 vaccine. This led to a massive spike in interest in British healthcare and life sciences companies, many of which sought to ...
Bates:Although global competition is increasing, the UK maintains a leadership position because of its traditional academic strengths in chemistry, basic biology and clinical science together with a pharma-experienced workforce. The UK science base remains globally competitive as measured by citations per...
Swiss pharma group is a high spender on R&D but has had misses in Alzheimer’s and cancer September 26 2024 Corporate governance Masimo founder seeks $400mn payout after board ousting Joe Kiani asserts in a California lawsuit that he is entitled to severance under provisions typically tied to...